RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
Ann Clin Biochem 2008;45:153-159
doi:10.1258/acb.2007.007091
© 2008 Association for Clinical Biochemistry

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, H. J.
Right arrow Articles by Niederau, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Original Article

Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography–tandem mass spectrometry as a reference

Heinz Jürgen Roth 1 , Heinrich Schmidt-Gayk 1, Holger Weber 2 and Christoph Niederau 3


1 Limbach Laboratory, Department of Endocrinology and Oncology, Im Breitspiel 15, 69126 Heidelberg, Germany; 2 Labor Prof G Enders und Partner, Rosenbergstraße 85, 70193 Stuttgart, Germany; 3 Labor Dr Niederau, Leopoldstr 10, 44147 Dortmund, Germany


Corresponding author: Heinz Jürgen Roth. Email: pablolim{at}aol.com


Background: The most reliable assessment of vitamin D status is measurement of plasma 25-hydroxyvitamin D (25[OH]D) concentration. High variability in 25(OH)D measurements due to utilized test and assay technologies and the lack of standardization against reference materials and reference method often confounds proper assessment of vitamin D status.

Methods: We evaluated the accuracy of six routinely available methodologies: high-performance liquid chromatography (HPLC), the IDS-radioimmunoassay (IDS-RIA) and enzyme immunoassay (IDS-EIA), the Nichols Advantage automated protein-binding assay (Advantage), two versions of the DiaSorin automated immunoassay (Liaison 1 and Liaison 2) – and one prototype automated immunoassay (Elecsys) for assessment of the 25(OH)D3 status in a cohort of 300 randomly selected patients' samples compared with the reference method liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Results: Passing-Bablok regression analysis demonstrated a slope for each method compared with LC-MS/MS that varied from 0.62 (IDS-EIA) to 1.0 (HPLC). The Advantage and the Liaison 1 showed significant deviation from linearity with highly variable individual results vs. the LC-MS/MS. Difference plots revealed a considerable persistent proportional bias for the IDS-RIA and IDS-EIA. All evaluated methods except HPLC demonstrated a more or less considerable deviation of individual 25(OH)D3 values compared with LC-MS/MS defined target concentrations.

Conclusions: Standardization of methods for the quantification of 25(OH)D on a human-based sample panel by means of LC-MS/MS would help to reduce the inter-method variability with respect to accuracy existing in 25(OH)D measurement considerably. However, there will still remain differences in the accuracy of methods utilizing sample purification before final quantification or immunological reaction when compared with those methods without separate sample purification.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Ashraf, J. Alvarez, K. Saenz, B. Gower, K. McCormick, and F. Franklin
Threshold for Effects of Vitamin D Deficiency on Glucose Metabolism in Obese Female African-American Adolescents
J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3200 - 3206.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. D. Carter
25-Hydroxyvitamin D Assays: The Quest For Accuracy
Clin. Chem., July 1, 2009; 55(7): 1300 - 1302.
[Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
K. D. Crew, M. D. Gammon, S. E. Steck, D. L. Hershman, S. Cremers, E. Dworakowski, E. Shane, M. B. Terry, M. Desai, S. L. Teitelbaum, et al.
Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk
Cancer Prevention Research, June 1, 2009; 2(6): 598 - 604.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
S. Knox, J. Harris, L. Calton, and A M. Wallace
A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry
Ann Clin Biochem, May 1, 2009; 46(3): 226 - 230.
[Abstract] [Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
J. D. McNALLY, L. A. MATHESON, and A. M. ROSENBERG
Epidemiologic Considerations in Unexplained Pediatric Arthralgia: The Role of Season, School, and Stress
J Rheumatol, February 1, 2009; 36(2): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
W. D Fraser
Standardization of vitamin D assays: art or science?
Ann Clin Biochem, January 1, 2009; 46(1): 3 - 4.
[Full Text] [PDF]


Home page
Ann Clin BiochemHome page
S J Costelloe, E Woolman, S Rainbow, L Stratiotis, G O'Garro, S Whiting, and M Thomas
Is high-throughput measurement of 25-hydroxyvitamin D3 without 25-hydroxyvitamin D2 appropriate for routine clinical use?
Ann Clin Biochem, January 1, 2009; 46(1): 86 - 87.
[Full Text] [PDF]


Home page
Ann Clin BiochemHome page
H. J. Roth
Response to Costelloe et al.
Ann Clin Biochem, January 1, 2009; 46(1): 87 - 88.
[Full Text] [PDF]



Acute CT - A Primer of Emergency Imaging